One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption
Journal of Bone and Mineral Research - United States
doi 10.1002/jbmr.3003
Full Text
Open PDFAbstract
Available in full text
Date
October 17, 2016
Authors
Publisher
Wiley